These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36327053)

  • 61. Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease.
    Chung GE; Kim MJ; Yim JY; Kim JS; Yoon JW
    J Obes Metab Syndr; 2019 Jun; 28(2):129-138. PubMed ID: 31294345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease.
    Kim Y; Han E; Lee JS; Lee HW; Kim BK; Kim MK; Kim HS; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Lee YH; Kim SU
    Gut Liver; 2022 Mar; 16(2):290-299. PubMed ID: 34238770
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    Kang MK; Park JG; Lee HJ; Kim MC
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1633-1640. PubMed ID: 30667551
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
    Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
    Feldman A; Eder SK; Felder TK; Kedenko L; Paulweber B; Stadlmayr A; Huber-Schönauer U; Niederseer D; Stickel F; Auer S; Haschke-Becher E; Patsch W; Datz C; Aigner E
    Am J Gastroenterol; 2017 Jan; 112(1):102-110. PubMed ID: 27527746
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway.
    Sebastiani G; Milic J; Gioe C; Al Hinai AS; Cervo A; Lebouche B; Deschenes M; Cascio A; Mazzola G; Guaraldi G
    Lancet HIV; 2022 Mar; 9 Suppl 1():S4. PubMed ID: 35304846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between non-alcoholic fatty liver disease and silent carotid plaque in Chinese aged population: a cross-sectional study.
    Zhang Y; Xu R; Ai L; Fan Z
    Ann Palliat Med; 2020 Mar; 9(2):182-189. PubMed ID: 32156140
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea.
    Lee HJ; Chang JS; Ahn JH; Kim MY; Park KS; Ahn YS; Koh SB
    J Prev Med Public Health; 2021 Nov; 54(6):412-421. PubMed ID: 34875824
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.
    Wijarnpreecha K; Panjawatanan P; Aby E; Ahmed A; Kim D
    Maturitas; 2019 Jun; 124():48-54. PubMed ID: 31097179
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.
    Wang YM; Zhu KF; Zhou WJ; Zhang Q; Deng DF; Yang YC; Lu WW; Xu J; Yang YM
    BMC Geriatr; 2021 Jan; 21(1):55. PubMed ID: 33446095
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus].
    Jiang H; Cheng QF; Zhu BZ; Yang Q
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):977-982. PubMed ID: 34814392
    [No Abstract]   [Full Text] [Related]  

  • 72. Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus.
    Cervo A; Milic J; Mazzola G; Schepis F; Petta S; Krahn T; Lebouche B; Deschenes M; Cascio A; Guaraldi G; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(10):e694-e701. PubMed ID: 32280969
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
    Prasetya IB; Hasan I; Wisnu W; Rumende CM
    Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk.
    Kuchay MS; Martínez-Montoro JI; Kaur P; Fernández-García JC; Ramos-Molina B
    Ageing Res Rev; 2022 Sep; 80():101696. PubMed ID: 35843589
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male.
    Pan XY; Liu WY; Zhu PW; Li G; Tang LJ; Gao F; Huang OY; Yuan HY; Targher G; Byrne CD; Wang XD; Zheng MH
    Hepatol Int; 2022 Oct; 16(5):1085-1093. PubMed ID: 35829867
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    Gao F; Zheng KI; Zhu PW; Li YY; Ma HL; Li G; Tang LJ; Rios RS; Liu WY; Pan XY; Targher G; Byrne CD; Chen YP; Zheng MH
    Br J Nutr; 2021 Sep; 126(6):813-824. PubMed ID: 33198849
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease.
    Kang MK; Kim KO; Kim MC; Park JG; Jang BI
    Dig Dis; 2020; 38(6):507-514. PubMed ID: 32135539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.